Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06371729
Status:
RECRUITING
Last Update Posted:
2024-06-18
First Post:
2024-04-10
Brief Title:
DEEP Substrate Mapping Versus Activation Mapping for VT
Sponsor:
IRCCS Ospedale San Raffaele
Organization:
IRCCS Ospedale San Raffaele
Study Overview
Official Title:
Substrate-based DEEP Mapping Versus Activation Mapping A Prospective Randomized Multicenter Study
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Substrate-based DEEP mapping and activation mapping are two of the main techniques used for guiding ventricular tachycardia VT ablation There is no data comparing directly the extent of applicability procedural results and the long-term outcomes between the two mapping strategiesThis randomized clinical trial aims to test whether activation mapping is superior to DEEP mapping to reduce ventricular tachycardia recurrence
The primary endpoint of the study is to compare recurrence-free survival rate of ventricular tachycardia at 12 months and procedural feasibility of substrate-based DEEP mapping versus activation mapping for VT ablation
The primary endpoint of the study is to compare recurrence-free survival rate of ventricular tachycardia at 12 months and procedural feasibility of substrate-based DEEP mapping versus activation mapping for VT ablation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None